AzTrials
AzTrials

Weight LossNCT03811743

A Coordinated Parent/Child Dyad Weight Loss Intervention: Dyad Plus (Feasibility)

A study testing Brenner FIT, By Design and Coordination in people with Weight Loss and Pediatric Obesity, run by Wake Forest University Health Sciences at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this research is to develop a coordinated program (Dyad Plus) that would help to facilitate self-monitoring, positive communication, joint problem solving, and social support to increase physical activity, healthy eating, and weight loss. Read more about this study

Who is it for?
Ages 13 to 65 years
Conditions the study is for
Weight Loss, Pediatric Obesity
What is being tested?
Brenner FIT, By Design and Coordination
Could I receive a placebo?
No, everyone receives an active treatment
How many people
16 participants
Where
1 siteUnited States
Study dates
25 Feb 2020to 16 Jun 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 to 65 years
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Eligible for enrollment in Brenner FIT and/or By Design Essentials
  • Caregiver who lives in the house with a BMI > 30
  • No contraindication for physical activity or caloric restriction
  • Must be able to read and write English

Who cannot join

  • Over the age of 65
  • BMI < 30
  • Contraindication for physical activity or caloric restriction
  • Cannot read or write English

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Wake Forest Baptist Medical Center

    Winston-Salem, North Carolina, 27157

Other trials in United States

About this study

The purpose of this research is to develop a coordinated program (Dyad Plus) that would help to facilitate self-monitoring, positive communication, joint problem solving, and social support to increase physical activity, healthy eating, and weight loss. Participants of the Brenner FIT (Families In Training) pediatric weight management program and their parent/guardian will co-enroll in weight loss programs. Parents/guardians will receive the components of By Design Essentials.

Read the detailed description

Participation in this study will involve participation in six, one-hour sessions in addition to those required by your weight loss program. These sessions will work to facilitate an increase in self-monitoring, positive communication, problem solving, and social support to increase healthy physical activity and eating behaviors to increase the effectiveness of the weight loss programs. Joint goal setting and tracking will be enabled by commercially available devices and apps. Each caregiver and child will receive an activity monitor, activity app, and a food app (digital food diary) that allows self-monitoring of consumption and "social accountability," which will allow caregivers and the Brenner FIT team to monitor and encourage. Furthermore, two home visits will be conducted to evaluation the home food and activity environments to inform tailored feedback to families.

Brenner FIT is a family-based pediatric weight management clinic for youth 2-18 years old referred by a physician for overweight or obesity.11-14 By Design is an adult (>18yrs) weight loss clinic that includes tailored dietary and physical activity behavioral counseling. The preliminary data suggest that most adolescent youth who enroll in Brenner FIT have at least one adult caregiver who is eligible and would benefit from enrollment in By Design Essentials.

Being tested
Brenner FIT, By Design, Coordination
Keywords
Youth, Parents, Overweight, Families
Medical subject headings
Weight Loss, Pediatric Obesity, Overweight

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Brenner FITBehavioural

    Brenner FIT pediatric weight management program enrollment. an interdisciplinary, family-based pediatric weight management clinic based upon the Familial Approach to Treatment of Childhood Obesity. Patients are referred by a physician for obesity or overweight with a weight-related comorbidity. Treatment teams are comprised of a pediatrician, counselor, dietitian, and physical activity specialist, with others (e.g., social workers, physical therapists) as needed. The entire family is encouraged to attend all aspects of the treatment program, although only one attending caregiver is required.

  • By DesignBehavioural

    Weight loss program for adults/caregivers of those enrolled in Brenner FIT. Participants in the By Design condition (adult caregivers) will be prescribed the Essentials lifestyle intervention which includes tailored dietary and physical activity goals designed to achieve 1-2 lbs./week of weight loss, provided by a multidisciplinary team of medical providers, dietitians, behaviorists, and exercise specialists. A daily calorie restriction of 500 kcal/day is prescribed based on estimates of total energy expenditure (TEE) obtained from a measured resting metabolic rate (RMR) prior to enrollment.

  • CoordinationBehavioural

    This component adds four additional strategies: dyad group sessions, one-on-one parent/child communication sessions, joint goal setting/tracking, and home environment assessment. This innovative approach will seek to employ components of motivation and communication theories to increase self-monitoring, positive communication, problem solving, and social support to increase healthy physical activity and eating behaviors to increase the effectiveness of the weight loss programs beyond gains observed in matched controls.

    Essentials (adults), with four additional components: dyad group sessions, one-on-one parent/child communication sessions, joint goal setting/tracking, and home environment assessment

Study groups in NCT03811743
Study groupRoleWhat they receive
Adolescents ParticipantsExperimentalAdolescents will participate in the Dyad Plus program along with their caregivers. The Dyad plus program consist of the combination of two existing programs (Brenner FIT for adolescents and By Design for the adult caregivers) with a new, novel coordination component
Receives: Behavioral: Brenner FIT; Behavioral: Coordination
Caregivers of adolescents participantsExperimentalAdult caregivers will participate in the Dyad Plus program along with their youth participants. The Dyad plus program consist of the combination of two existing programs (Brenner FIT for adolescents and By Design for the adult caregivers) with a new, novel coordination component
Receives: Behavioral: By Design; Behavioral: Coordination

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. BMI z-score

    Weight status of caregivers and youth will be quantified through calculation of BMI derived from measurement of height and weight at the intake and follow-up visits. Both height (plus or minus 0.1 cm) and weight (plus or minus 0.5 kg) will be recorded twice and values will be averaged to produce the final value using a Tanita (registered trademark) digital scale and a Seca (registered trademark) Height Rod (respectively). BMI will be calculated as kg /m2. BMI z-score will be calculated using CDC growth charts.

    Measured: Baseline

  2. BMI z-score

    Weight status of caregivers and youth will be quantified through calculation of BMI derived from measurement of height and weight at the intake and follow-up visits. Both height (plus or minus 0.1 cm) and weight (plus or minus 0.5 kg) will be recorded twice and values will be averaged to produce the final value using a Tanita (registered trademark) digital scale and a Seca (registered trademark) Height Rod (respectively). BMI will be calculated as kg /m2. BMI z-score will be calculated using CDC growth charts.

    Measured: 3 Months

  3. BMI z-score

    Weight status of caregivers and youth will be quantified through calculation of BMI derived from measurement of height and weight at the intake and follow-up visits. Both height (plus or minus 0.1 cm) and weight (plus or minus 0.5 kg) will be recorded twice and values will be averaged to produce the final value using a Tanita (registered trademark) digital scale and a Seca (registered trademark) Height Rod (respectively). BMI will be calculated as kg /m2. BMI z-score will be calculated using CDC growth charts.

    Measured: 6 months

Secondary outcomes (21)
  1. Physical Activity Assessed by Accelerometry

    Physical activity data will be collected using ActiGraph (trademark) accelerometers worn continuously over 7 days except during bathing and sleeping. Moderate to vigorous activity will be measured in minutes.

    Measured: Baseline

  2. Physical Activity Assessed by Accelerometry

    Physical activity data will be collected using ActiGraph (trademark) accelerometers worn continuously over 7 days except during bathing and sleeping. Moderate to vigorous activity will be measured in minutes.

    Measured: 6 months

  3. Physical Activity Assessed by PAQ-A

    The Physical Activity Questionnaire for Adolescents (PAQ-A) will be given to assess physical activity.

    The PAQ-A ranges from 1-7. Higher score denotes better outcome.

    Measured: Baseline

  4. Physical Activity Assessed by PAQ-A

    The Physical Activity Questionnaire for Adolescents (PAQ-A) will be given to assess physical activity.

    The PAQ-A ranges from 1-7. Higher score denotes better outcome.

    Measured: 6 months

  5. Physical Activity Assessed by IPAQ

    The International Physical Activity Questionnaire (IPAQ) will be given to assess physical activity in adults.

    The IPAQ ranges from 10-960 minutes/day of physical activity. Higher score denotes better outcome.

    Measured: Baseline

  6. Physical Activity Assessed by IPAQ

    The International Physical Activity Questionnaire (IPAQ) will be given to assess physical activity in adults.

    The IPAQ ranges from 10-960 minutes/day of physical activity. Higher score denotes better outcome.

    Measured: 6 months

  7. Caloric intake expressed in kcals

    Diet will be assessed by the Automated Self-Administered 24-hour (ASA24) dietary assessment tool.

    Measured: Baseline

  8. Caloric intake expressed in kcals

    Diet will be assessed by the Automated Self-Administered 24-hour (ASA24) dietary assessment tool.

    Measured: 6 months

  9. Concentration of fasting glucose for all participants, mg/dL

    Fasting blood glucose will be ascertained for each participant. A fasting blood sugar level less than 100 mg/dL (5.6 mmol/L) is optimal. A fasting blood sugar level from 100 to 125 mg/dL (5.6 to 6.9 mmol/L) is considered prediabetes.

    Measured: Baseline

  10. Concentration of fasting glucose for all participants, mg/dL

    Fasting blood glucose will be ascertained for each participant. A fasting blood sugar level less than 100 mg/dL (5.6 mmol/L) is optimal. A fasting blood sugar level from 100 to 125 mg/dL (5.6 to 6.9 mmol/L) is considered prediabetes.

    Measured: 6 months

  11. Concentration of fasting Insulin for all participants, mg/dL

    Fasting insulin levels will be gathered from all participants.

    Measured: Baseline

  12. Concentration of fasting Insulin for all participants, mg/dL

    Fasting insulin levels will be gathered from all participants.

    Measured: 6 months

  13. Hemoglobin A1c concentration for all participants, measured in percentage

    Normal range for the hemoglobin A1c level is between 4% and 5.6%. Hemoglobin A1c levels between 5.7% and 6.4% Values greater denote diabetes.

    Measured: Baseline

  14. Hemoglobin A1c concentration for all participants, measured in percentage

    Normal range for the hemoglobin A1c level is between 4% and 5.6%. Hemoglobin A1c levels between 5.7% and 6.4%. Values greater denote diabetes.

    Measured: 6 months

  15. Aspartate Aminotransferase -Levels of AST for all participants, measured in units per liter (IU/L)

    AST a useful test for detecting or monitoring liver damage.

    Measured: Baseline

  16. Aspartate Aminotransferase -Levels of AST for all participants, measured in units per liter (IU/L)

    AST a useful test for detecting or monitoring liver damage.

    Measured: 6 months

  17. Alanine Aminotransferase-Levels of ALT for all participants, measured in units per liter

    A low level of ALT in the blood is expected and is normal.

    Measured: Baseline

  18. Alanine Aminotransferase-Levels of ALT for all participants, measured in units per liter

    A low level of ALT in the blood is expected and is normal.

    Measured: 6 months

  19. Concentration of total cholesterol (mg/dL)

    total cholesterol: less than 200 mg/dL

    Measured: Baseline

  20. Concentration of total cholesterol (mg/dL)

    total cholesterol: less than 200 mg/dL

    Measured: 6 months

  21. Economic costs of the three intervention arms over duration of program (USD)

    Clinical and non-clinical costs of the interventions will be compiled over the duration of the program. All cost will be reported in the same unit.

    Measured: Baseline through 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jan 2019
  2. Study start25 Feb 2020
  3. Primary completion16 Jun 2020
  4. Study completion16 Jun 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
16 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03811743
Sponsor's protocol ID
IRB00055004
Status last verified
May 2021
First submitted
10 Jan 2019
Last updated
22 Mar 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Skelton JA, Beech BM. Attrition in paediatric weight management: a review of the literature and new directions. Obes Rev. 2011 May;12(5):e273-81. doi: 10.1111/j.1467-789X.2010.00803.x. Epub 2010 Sep 29.

    PubMed 20880126

Questions about this trial

What is this clinical trial studying?

A study testing Brenner FIT, By Design and Coordination in people with Weight Loss and Pediatric Obesity, run by Wake Forest University Health Sciences at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

BMI z-score (time frame: Baseline). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03811743, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Mar 2023; AzTrials last refreshed its copy on 4 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in